Search results for "Effusion"

showing 10 items of 103 documents

Comparison between CA125 and NT-proBNP for evaluating congestion in acute heart failure

2020

Abstract Background Carbohydrate antigen 125 (CA125) and B-type natriuretic peptides are surrogate markers of congestion in patients with acute heart failure (AHF). The aim of the study was to assess the association between CA125 and NT-proBNP and congestion parameters in patients with AHF. Methods and results Prospective multicentre observational study that included 191 patients hospitalised for AHF. We recorded the presence of pleural effusion, peripheral oedema and inferior vena cava (IVC) diameter during the first 24–48 h after admission and evaluated their independent association with CA125 concentrations and the amino-terminal fraction of pro-B-type natriuretic peptide (NT-proBNP). Th…

Malemedicine.medical_specialtyendocrine system diseasesmedicine.drug_classPleural effusionPeripheral edemaInferior vena cavaVentricular Function LeftInternal medicineNatriuretic Peptide BrainmedicineNatriuretic peptideHumansIn patientProspective StudiesAgedAged 80 and overHeart FailureEjection fractionbusiness.industryStroke VolumeMiddle AgedPrognosismedicine.diseasePeptide Fragmentsmedicine.veinHeart failureCardiologySerum ca125Femalemedicine.symptombusinessBiomarkersMedicina Clínica (English Edition)
researchProduct

A comparison of the effects of Methylprednisolone Acetate, Sodium Hyaluronate and Tenoxicam in the treatment of non-reducing disc displacement of the…

2018

Background This clinical study aimed to radiologically and clinically compare the effect of intra-articular injection of methylprednisolone, sodium hyaluronate or tenoxicam following arthrocentesis with that of arthrocentesis alone in patients with non-reducing disc displacement. Material and Methods A total of 44 patients radiographically diagnosed with non-reducing disc displacement of the temporomandibular joint (TMJ) were randomly divided into four treatment groups, as follows: Group 1, arthrocentesis alone; Group 2, arthrocentesis plus methylprednisolone acetate; Group 3, arthrocentesis plus sodium hyaluronate; Group 4, arthrocentesis plus tenoxicam. Maximum mouth opening (MMO), latera…

Malemedicine.medical_treatmentSodium hyaluronateAnti-Inflammatory AgentsInjections Intra-Articular03 medical and health scienceschemistry.chemical_compoundPiroxicam0302 clinical medicineTenoxicamMedicineHumansSingle-Blind MethodProspective StudiesHyaluronic AcidGeneral Dentistrymedicine.diagnostic_testViscosupplementsbusiness.industryResearchAnti-Inflammatory Agents Non-SteroidalArthrocentesisMagnetic resonance imaging030206 dentistryMethylprednisolone acetateTemporomandibular Joint Disorders:CIENCIAS MÉDICAS [UNESCO]Combined Modality TherapyTemporomandibular jointMethylprednisolone Acetatemedicine.anatomical_structureOtorhinolaryngologychemistryEffusionMethylprednisolone030220 oncology & carcinogenesisAnesthesiaUNESCO::CIENCIAS MÉDICASSurgeryFemaleOral Surgerybusinessmedicine.drugArthrocentesisMedicina Oral, Patología Oral y Cirugía Bucal
researchProduct

Bacterial Cytolysin Perturbs Round Window Membrane Permeability Barrier In Vivo: Possible Cause of Sensorineural Hearing Loss in Acute Otitis Media

1998

ABSTRACT The passage of radioiodinated streptolysin-O (SLO) and albumin through the round window membrane (RWM) was studied in vivo. When applied to the middle ear, SLO became quantitatively entrapped in this compartment and no passage to the cochlea occurred. However, flux of radioiodinated albumin through the toxin-damaged RWM was observed. We propose that the passage of noxious macromolecules, such as proteases, from a purulent middle-ear effusion may be facilitated by pore-forming toxins, resulting in cochlear damage and sensorineural hearing loss.

Membrane permeabilityHearing lossHearing Loss SensorineuralImmunologyGuinea PigsBiologyIn Vitro TechniquesMicrobiologyPermeabilityBacterial ProteinsIn vivoAlbuminsmedicineotorhinolaryngologic diseasesAnimalsCochleaRound windowMembranesOtitis Media with EffusionAnatomyBacterial Infectionsmedicine.diseaseCochleaInfectious Diseasesmedicine.anatomical_structureRound Window EarStreptolysinsBiophysicsMiddle earParasitologySensorineural hearing lossCytolysinsense organsmedicine.symptom
researchProduct

Immunocytochemical typification of mesothelial cells in effusions: in vivo and in vitro models.

1994

We have performed immunocytochemical, immunoelectron microscopy, Western blot, and culture techniques using monoclonal antibodies against cytokeratin, vimentin, and desmin on 17 benign and 20 malignant effusions of pleural and ascitic origin. Triple coexpression of these three antigens was observed in benign reactive mesothelial cells as well as in one case of mesothelioma. All metastatic adenocarcinoma cells were consistently negative to desmin and positive to cytokeratin and vimentin. Present results were helpful to distinguish reactive and malignant mesothelioma from metastatic carcinoma cells in effusions.

MesotheliomaPathologymedicine.medical_specialtyHistologyImmunoelectron microscopyBlotting WesternVimentinmacromolecular substancesBiologyAdenocarcinomaModels BiologicalEpitheliumPathology and Forensic MedicineMetastatic carcinomaDesminDiagnosis DifferentialImmunoenzyme TechniquesPleural diseaseCytokeratinmedicineAscitic FluidHumansVimentinCells CulturedGeneral Medicinemedicine.diseasePleural Effusionbiology.proteinAdenocarcinomaKeratinsDesminFemaleMesothelial CellFollow-Up StudiesDiagnostic cytopathology
researchProduct

Fluconazole concentrations in pulmonary tissue and pericardial fluid

1997

In order to investigate the clinical efficacy of the triazole antifungal agent fluconazole (FCA) in the treatment of pulmonary mycosis, in the present study the concentrations of fluconazole in human pulmonary tissue, pericardial fluid and serum were determined at 1, 2, 12 and 13 h after intravenous administration of fluconazole 200 mg. The mean FCA concentrations in the serum were 4.04 mg/l (1 h), 3.82 mg/l (2 h), 2.35 mg/l (12 h) and 2.13 mg/l (13 h). The respective FCA levels in the pulmonary tissue were 4.64 mg/kg, 4.54 mg/kg; 3.50 mg/kg and 3.40 mg/kg and the concentrations in the pericardial fluid were 3.86 mg/l, 3.57 mg/l, 2.35 mg/l and 2.13 mg/l. The FCA concentrations in the pulmon…

Microbiology (medical)Antifungal AgentsMetabolic Clearance Ratemedicine.medical_treatmentTriazoleBiological AvailabilityPharmacologyPericardial Effusionchemistry.chemical_compoundPharmacokineticsCricetinaemedicineAnimalsHumansPericardiumInfusions IntravenousFluconazoleLungMycosisChemotherapyLungbusiness.industryPericardial fluidGeneral Medicinemedicine.diseaseInfectious Diseasesmedicine.anatomical_structurechemistryAnesthesiabusinessFluconazolemedicine.drugInfection
researchProduct

A severe case of Israeli spotted fever with pleural effusion in Italy

2021

Abstract Background The most common Italian rickettsiosis is Mediterranean Spotted Fever (MSF). MSF is commonly associated with a symptom triad consisting of fever, cutaneous rash, and inoculation eschar. The rash is usually maculopapular but, especially in severe presentations, may be petechial. Other typical findings are arthromyalgia and headache. Herein, we describe for the first time an unusual case of Israeli spotted fever (ISF) associated with interstitial pneumonia and pleural effusion in which R. conorii subsp. israelensis was identified by molecular methods in the blood, as well as in the pleural fluid. Case presentation A 72-year-old male presented with a 10-day history of remitt…

Microbiology (medical)Malemedicine.medical_specialtySettore MED/07 - Microbiologia E Microbiologia ClinicaItaly Mediterranean spotted fever Pleural effusion Rickettsia Rickettsiales RickettsiosisSettore MED/17 - Malattie InfettivePleural effusionmedicine.medical_treatmentRickettsialesThoracentesisCase ReportEscharRickettsiosisBoutonneuse FeverMedicineHumansRickettsiaAgedbusiness.industryMediterranean spotted feverRickettsia InfectionsGeneral MedicinePetechial rashSpotted Fever Group Rickettsiosismedicine.diseaseRashDermatologyPleural effusionSpotted feverPneumoniaInfectious DiseasesRickettsiosisItalymedicine.symptombusinessInfection
researchProduct

Liquid biopsies in lung cancer: The new ambrosia of researchers

2014

Abstract: In the last decades the approach to cancer patient management has been deeply revolutionized. We are moving from a "one-fits-all" strategy to the "personalized medicine" based on the molecular characterization of the tumor. In this new era it is becoming more and more clear that the monitoring of the disease is fundamental for the success of the treatment, thus there is the need of new biomarker discovery. More precisely in the last years the scientific community has started to use the term "liquid biopsy". A liquid biopsy is a liquid biomarker that can be easily isolated from many body fluids (blood, saliva, urine, ascites, pleural effusion, etc.) and, as well as a tissue biopsy,…

OncologyCancer Researchmedicine.medical_specialtyLung NeoplasmsPleural effusionSettore MED/06 - Oncologia MedicaBiopsyexosomescirculating tumor cellsCirculating tumor cellSettore BIO/13 - Biologia ApplicataInternal medicineSettore BIO/10 - BiochimicaGeneticsmedicineBiomarkers TumorexosomeAnimalsHumanscancerBiomarker discoveryLiquid biopsyLung cancerBiologyliquid biopsybusiness.industryPhysicsCancerDNA Neoplasmmedicine.diseaseNeoplastic Cells CirculatingChemistryOncologyImmunologyBiomarker (medicine)Human medicinePersonalized medicineliquid biopsy; cancer; exosomes; circulating tumor cellsbusiness
researchProduct

Cancer Stem Cells Sensitivity Assay (STELLA) in Patients with Advanced Lung and Colorectal Cancer: A Feasibility Study.

2015

Background Cancer stem cells represent a population of immature tumor cells found in most solid tumors. Their peculiar features make them ideal models for studying drug resistance and sensitivity. In this study, we investigated whether cancer stem cells isolation and in vitro sensitivity assay are feasible in a clinical setting. Methods Cancer stem cells were isolated from effusions or fresh cancer tissue of 23 patients who progressed after standard therapy failure. Specific culture conditions selected for immature tumor cells that express markers of stemness. These cells were exposed in vitro to chemotherapeutic and targeted agents. Results Cancer stem cells were extracted from liver metas…

OncologyMalemedicine.medical_specialtyLung NeoplasmsTime FactorsColorectal cancerTarget therapy drug sensitivity cancer stem cellsPopulationlcsh:MedicineAntineoplastic AgentsDrug resistanceCell SeparationCancer stem cellInternal medicinemedicineHumansIn patienteducationlcsh:ScienceAgedAged 80 and overSettore MED/04 - Patologia Generaleeducation.field_of_studyMultidisciplinaryLungbusiness.industrylcsh:RLiver NeoplasmsMiddle Agedmedicine.diseaseIn vitroClinical trialPleural EffusionDrug Combinationsmedicine.anatomical_structureLymphatic MetastasisNeoplastic Stem CellsFeasibility Studieslcsh:QFemaleDrug Screening Assays AntitumorbusinessColorectal NeoplasmsResearch Article
researchProduct

Congenital Plaque-Type Glomuvenous Malformations Associated with Fetal Pleural Effusion and Ascites

2010

Glomuvenous malformations are hereditary vascular anomalies, usually without extracutaneous involvement. We report two cases of extensive thoracic plaque-type glomuvenous malformation in newborns who had previously been diagnosed in utero with pleural effusion and ascites, suggesting a pathogenic link between the two conditions.

Pathologymedicine.medical_specialtyExtramuralbusiness.industryPleural effusionDermatologymedicine.diseaseGlomuvenous malformationIn uteroParagangliomaPediatrics Perinatology and Child HealthAscitesmedicinePlaque typeRadiologymedicine.symptomFetal pleural effusionbusinessPediatric Dermatology
researchProduct

2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases…

2015

Guidelines summarize and evaluate all available evidence on a particular issue at the time of the writing process, with the aim of assisting health professionals in selecting the best management strategies for an individual patient with a given condition, taking into account the impact on outcome, as well as the risk–benefit ratio of particular diagnostic or therapeutic means. Guidelines and recommendations should help health professionals to make decisions in their daily practice. However, the final decisions concerning an individual patient must be made by the responsible health professional(s) in consultation with the patient and caregiver as appropriate.

PericardiocentesiPrognosiMyopericarditiTamponadeConstrictive pericarditiPericardial effusionPericarditiTherapyAetiologyGuidelinePericardiumDiagnosi
researchProduct